Photo by camstejim from unsplash
Intravenous immunoglobulins (IVIGs) are a common therapy in patients with neuroinflammatory disorders, especially chronic inflammatory demyelinating polyradiculoneuropathy or Guillain−Barré syndrome. Hematological toxicities upon IVIG infusion are a known side effect… Click to show full abstract
Intravenous immunoglobulins (IVIGs) are a common therapy in patients with neuroinflammatory disorders, especially chronic inflammatory demyelinating polyradiculoneuropathy or Guillain−Barré syndrome. Hematological toxicities upon IVIG infusion are a known side effect and still an important subject of investigation.
Keywords:
platelet leukocyte;
leukocyte decline;
intravenous immunoglobulins;
patients neuroinflammatory;
neuroinflammatory disorders;
early platelet
Journal Title: European Journal of Neurology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: European Journal of Neurology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!